EuroscreenFast Announces Strategic Partnership with BioPharma Consultants to Expand GPCR Research Offering in India

EuroscreenFast, a leading provider of G-Coupled Protein Receptors (GPCR) screening & assay development services, is excited to announce a strategic partnership with BioPharma Consultants, a specialist Indian provider of life science technology solutions based in Pune. This partnership aims to strengthen the presence of EuroscreenFast in the Indian market with BioPharma Consultants as their local agent to bring their innovative GPCR expertise to where it is needed across the sub-continent.

 

This partnership brings EuroscreenFast’s cutting-edge GPCR discovery, screening and deorphanisation capabilities together with BioPharma Consultants’s extensive knowledge of the Indian market, offering a seamless experience for customers seeking advanced development solutions. As a pioneer in GPCR science for over 30 years, EuroscreenFast is committed to delivering high-quality, reliable, and timely screening services to support novel drug developers and generics manufacturers alike.

 

“We are thrilled to partner with BioPharma Consultants as we expand our reach into the Indian market,” said Dr Laurent Meeus, Chief Scientist & General Manager at EuroscreenFast. “Our offering is already well established in Europe, and by leveraging BioPharma Consultant’s extensive network, we know we can establish a similar reputation in India.”

 

Uday Ulhe, Founder & Managing Director of BioPharma Consultants, expressed excitement about the partnership, stating, “We are proud to join forces with EuroscreenFast and bring their GPCR offering to a new market, especially at a time when Indian companies are increasingly branching out, away from generic medicines and moving into the development of novel, innovative therapies. We already do a lot of work with Belgian companies, supporting their interests in India, so we know both markets well. We look forward to continuing that legacy with EuroscreenFast.”

 

Indian companies that are developing human therapeutics targeting are encouraged to contact BioPharma Consultants to advance their GPCR drug discovery programs using EuroscreenFast’s state-of-the-art technologies.

 

For more information, please contact: info@euroscreenfast.com